Latest News

A selection of recent news and views from Catapult Ventures follows...

Cytox strengthens team to support commercialisation of genoSCORE test to predict risk of cognitive decline due to Alzheimer’s disease

New appointments in Commercial Operations, Medical Affairs, and Bioinformatics & Genetics 26 July 2021: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's...

Women can buy Maxwellia’s Lovima® contraceptive pill from pharmacies for first time in UK history

WOMEN can now buy a contraceptive pill over the counter without a prescription following a consultation with a pharmacist after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today granted a licence to Maxwel...

QV Bioelectronics raises £735k for development of implanted electric field therapy device for brain cancer treatment

6th July 2021, Cheshire, UK.  QV Bioelectronics (“QV”) – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, anno...

Gendius - new partnership will help diabetics to manage their conditions

Experts at the University of Nottingham have teamed up with digital health company Gendius Limited to help promote better care for people with diabetes. Experts in the University’s Digital Research Service will work with Gendius Limited to...

Cambridge Cognition completes spin-out of Monument Therapeutics

Manchester, UK, July 1st, 2021: Monument Therapeutics, a stratified medicine company, today announced it has raised £2.625 million in seed funding to spin out of Cambridge Cognition Ltd and relocate to Alderley Park, Cheshire. The new compan...

From our portfolio

Biofortuna Limited


Biofortuna is a leading developer of HLA diagnostic test kits for the organ transplantation, bloo...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200